A Pilot Study Showing Acute Inhibitory Effect of GLP-1 on the Bone Resorption Marker CTX in Humans

Keyphrases

• Bone Turnover Markers 100%
• Inhibitory Effect 100%
• Glucagon-like 100%
• Amides 52%
• Exenatide 35%
• Placebo 23%
• 1 Receptor 17%
• Area under the Curve 11%
• Osteoprotegerin 11%
• Gut-bone Axis 11%
• IGF-1 Level 11%
• Human Bone 5%
• Receptor Agonist 5%
• Blinded Randomized Clinical Trial 5%
• Acute Effects 5%
• Effects on Humans 5%
• Healthy Normal 5%
• Normal Weight 5%
• Peak Plasma Concentration 5%
• Bone Resorption 5%
• Glucose-dependent Insulinotropic Polypeptide 5%
• Primary Metabolites 5%
• Bone Research 5%
• Mineral Research 5%
• American Society 5%
• Osteocalcin 5%
• EC50 5%
• Bone Remodeling Markers 5%
• Sigma-1 Receptor 5%
• Procollagen Type 1 N-terminal Propeptide (P1NP) 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucagon-Like Peptide-1 100%
• Exendin 4 75%
• Glucagon Like Peptide 1 [7-36] Amide 62%
• Placebo 50%
• Carboxamide 50%
• Parathyroid Hormone 25%
• Osteoprotegerin 25%
• Glucagon-Like Peptide 1 Receptor 25%
• Randomized Clinical Trial 12%
• Glucagon Like Peptide 2 12%
• Glucagon Like Peptide 1 Receptor Agonist 12%
• Gastric Inhibitory Polypeptide 12%
• Osteocalcin 12%
• Table Salt 12%
• EC50 12%